WASHINGTON — E-cigarette company Juul could eventually be allowed to resume selling its products in the U.S."The FDA had determined that the applications lacked sufficient evidence regarding the toxicological profile of the products to demonstrate that the marketing of the products met the public health standard required by law," the FDA wrote.
However, the agency noted that the ban reversal doesn't mean Juul products will end up back on U.S. shelves. Once accepted and filed by the FDA, applications under review either receive marketing granted orders or MDOs.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: